tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Doug Schenkel, 62 are a HOLD (30.1%), 143 are a BUY (69.42%), 1 are a SELL (0.49%).
Analyst Doug Schenkel, currently employed at UBS, carries an average stock price target met ratio of 81.21% that have a potential upside of 27.82% achieved within 217 days. Previously, Doug Schenkel worked at TD COWEN, COWEN, WOLFE.
Doug Schenkel’s has documented 396 price targets and ratings displayed on 39 stocks. The coverage is on Healthcare, Basic Materials, Industrials sectors.
Most recent stock forecast was given on VCYT, Veracyte at 09-Sep-2026.
Analyst best performing recommendations are on PACB (PACIFIC BIOSCIENCES OF CALIFORNIA).
The best stock recommendation documented was for GH (GUARDANT HEALTH) at 10/29/2018. The price target of $40 was fulfilled within 4 days with a profit of $7.41 (22.74%) receiving and performance score of 56.84.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$0.65
$0.51 (364.29%)
$3.35
3 years 4 months 15 days ago
(18-May-2023)
2/2 (100%)
$0.06 (10.17%)
10
Buy
$1.25
$1.2 (2400.00%)
$19
3 years 4 months 24 days ago
(10-May-2023)
3/4 (75%)
$2.13 (47.39%)
21
Buy
$5
$4.86 (3471.43%)
$30
3 years 6 months 17 days ago
(16-Mar-2023)
7/10 (70%)
$3.68 (278.79%)
819
Hold
$2
$1.86 (1328.57%)
$2.5
3 years 9 months ago
(03-Jan-2023)
1/2 (50%)
$0.55 (37.93%)
2
Hold
3 years 10 months 24 days ago
(09-Nov-2022)
1/2 (50%)
$7.57 (43.43%)
391
Which stock is Doug Schenkel most bullish on?
Which stock is Doug Schenkel most reserved on?
What Year was the first public recommendation made by Doug Schenkel?
